Skip to content

The effect of MultiPoint™ pacing on reverse remodelling and the incidence of ventricular arrhythmias – The MPP VARR Study

Does MultiPoint™ pacing (MPP) result in a greater rate of reverse remodelling in participants receiving cardiac resynchronisation therapy (CRT) when compared to conventional CRT and to assess if the rate of ventricular arrhythmias is affected with MPP?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36496918
Enrollment
344
Registered
2017-02-20
Start date
2016-10-26
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal heart rhythms Circulatory System

Interventions

Participants undergoing CRT- D implant will either be randomised to have the pacemaker set at the conventional method of pacing the left side of the heart from one location (MPP off) or will have the

Sponsors

Guy's and St Thomas' NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo an implant of a CRT-D system with approved standard indication by ESC/EHRA guidelines 2. Ability to provide informed consent for study participation and be willing to comply with the enrolment and follow up evaluations 3. Aged 18 years and over

Exclusion criteria

Exclusion criteria: 1. Recent myocardial infarction within 40 days prior to enrolment 2. Cardiac surgery or coronary revascularisation procedure within 3 months prior to enrolment or be scheduled for such procedures in the following 7 months 3. Intravenous inotropic support within the last 30 days 4. Under 18 years of age 5. Be pregnant or plan to become pregnant over the next 7 months

Design outcomes

Primary

MeasureTime frame
Rate of left ventricular reverse remodelling is measured using LV volume reduction at 6 months.

Secondary

MeasureTime frame
Changes in the incidence of treated ventricular arrhythmias is measured by the number of incidents reported over the duration of the 2 years participant is in the study.

Countries

United Kingdom

Contacts

Public ContactMatthew Osmond
Matthew.osmond@gstt.nhs.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026